Cardinal Health (CAH) Tops Q4 EPS by 7c; Guides Short of Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Cardinal Health (CAH) PT Lowered to $77 at Cowen Following 4Q Report
August 2, 2017 4:05 PM EDTCowen lowered its price target on Cardinal Health (NYSE: CAH) to $77.00 (from $82.00) while maintaining a Market Perform rating. CAH reported adjusted EPS of $1.31 that was above the consensus estimates of $1.24, but would have missed without a tax benefit.
Management announced F2018 adjusted EPS... More
